U.S. markets open in 2 hours 53 minutes

Walgreens Boots Alliance, Inc. (WBA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
47.93-0.34 (-0.70%)
At close: 4:00PM EST

48.20 +0.27 (0.56%)
Pre-Market: 5:49AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close48.27
Bid47.81 x 1100
Ask48.99 x 1200
Day's Range47.55 - 48.59
52 Week Range33.36 - 55.49
Avg. Volume6,891,425
Market Cap41.414B
Beta (5Y Monthly)0.47
PE Ratio (TTM)N/A
EPS (TTM)-0.80
Earnings DateMar 31, 2021 - Apr 05, 2021
Forward Dividend & Yield1.87 (3.87%)
Ex-Dividend DateFeb 18, 2021
1y Target Est46.61
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-41% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Barrons.com

    Why Oracle Was Late to the Cloud

    Letters on Oracle’s cloud-computing business, Vanguard, Felix Zulauf, short-term interest rates, Warren Buffett’s buybacks, and market predictions

  • 3 Pharmacies & Drugstore Stocks to Watch Amid COVID-19 Resurgence

    3 Pharmacies & Drugstore Stocks to Watch Amid COVID-19 Resurgence

    3 Pharmacies & Drugstore Stocks to Watch Amid COVID-19 Resurgence

  • MarketWatch

    Walgreens to start selling at-home COVID-19 tests

    Shares of Walgreens Boots Alliance Inc. gained 0.3% in trading on Thursday, the day after the pharmacy giant said it will begin selling over-the-counter COVID-19 tests developed by the Laboratory Corporation of America Holdings . Labcorp's stock was down 1.8%. The at-home PCR test kits will be sold at pharmacy counters in an estimated 6,000 Walgreens stores in the U.S. sometime this spring, allowing people to buy a kit, self-administer a nasal swab, and mail the sample back to Labcorp via FedEx. People do not need a prescription to purchase the test kit. A Walgreens spokesperson said in an email that it is not disclosing the price of the test at this time. Over the past 12 months, Walgreen's stock has gained 4.1% and shares of Labcorp are up 29.9%. The S&P 500 is up 21.7%.